跳至主要内容
临床试验/PACTR201705002282393
PACTR201705002282393尚未招募未知

The role of epigenetic modifications in autism spectrum disorder through DNA methylation

the Vice Dean Research Office.0 个研究点目标入组 40 人开始时间: 2017年5月10日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 Year(s) 至 6 Year(s)(—)
性别
All

入选标准

  • a. All enrolled children with ASD will be:
  • 1-Exhibit symptoms within the typical triad of autistic traits: communication impairment, social deficits, and ritualistic interests.
  • 2-2-6 years old.
  • 3-Drug-naïve.

排除标准

  • The control subjects will also clinically examined by the psychiatrist to exclude any sub-clinical autistic features. Children with ASD and controls will excluded from the study if
  • 2-They receive treatment for any reason.
  • 3--Endocrinological disease, mental retardation, communication disorder, psychotic disorder, attention deficit hyperactivity disorder and learning disorders seen in the children or their family members.

研究者

发起方
the Vice Dean Research Office.

相似试验